понедельник, 6 июня 2011 г.

Риски и преимущества перехода на терапию одним антипсихотическим препаратом

The study did find that treatment discontinuation was more common in the group that switched to monotherapy than in the polypharmacy group, but the symptom control and weight loss associated with the switch to monotherapy suggests that monotherapy may be an option worth trying for patients who are relatively stable.

Monotherapy After Polypharmacy Effective for Some Patients

Комментариев нет:

Отправить комментарий